The psilocybin market is booming, projected to reach $1.6 billion by 2033, driven by clinical trials showing its potential to treat depression, anxiety, and PTSD. Explore the market size, growth trends, leading companies (Compass Pathways, ATAI Biosciences), and regional analysis in our comprehensive report.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
